COVID-19 - deliberating beyond steroids in 2021

Adv Respir Med. 2021;89(6):612-614. doi: 10.5603/ARM.a2021.0114.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • Immunosuppressive Agents* / adverse effects
  • Immunosuppressive Agents* / therapeutic use
  • India
  • Steroids

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Steroids
  • tocilizumab